{"id":1007,"date":"2025-10-21T18:45:51","date_gmt":"2025-10-21T16:45:51","guid":{"rendered":"https:\/\/www.itpptibelgium.be\/pti-et-science\/"},"modified":"2026-09-23T18:18:31","modified_gmt":"2026-09-23T16:18:31","slug":"pti-et-science","status":"publish","type":"page","link":"https:\/\/www.itpptibelgium.be\/fr\/vivre-avec-la-pti\/pti-et-science\/","title":{"rendered":"PTI et science"},"content":{"rendered":"<style>.wp-block-kadence-advancedheading.kt-adv-heading340_2b75cb-7b_1, .wp-block-kadence-advancedheading.kt-adv-heading340_2b75cb-7b_1[data-kb-block=\"kb-adv-heading340_2b75cb-7b_1\"]{font-style:normal;}.wp-block-kadence-advancedheading.kt-adv-heading340_2b75cb-7b_1 mark.kt-highlight, .wp-block-kadence-advancedheading.kt-adv-heading340_2b75cb-7b_1[data-kb-block=\"kb-adv-heading340_2b75cb-7b_1\"] mark.kt-highlight{font-style:normal;color:#f76a0c;-webkit-box-decoration-break:clone;box-decoration-break:clone;padding-top:0px;padding-right:0px;padding-bottom:0px;padding-left:0px;}.wp-block-kadence-advancedheading.kt-adv-heading340_2b75cb-7b_1 img.kb-inline-image, .wp-block-kadence-advancedheading.kt-adv-heading340_2b75cb-7b_1[data-kb-block=\"kb-adv-heading340_2b75cb-7b_1\"] img.kb-inline-image{width:150px;vertical-align:baseline;}<\/style>\n<p class=\"kt-adv-heading340_2b75cb-7b_1 wp-block-kadence-advancedheading\" data-kb-block=\"kb-adv-heading340_2b75cb-7b_1\">Les connaissances m\u00e9dicales sur la PTI ne cessent d&rsquo;\u00e9voluer, ce qui est une bonne nouvelle pour les patients et les prestataires de soins. Des chercheurs du monde entier se penchent sur les m\u00e9canismes sous-jacents, la qualit\u00e9 de vie et les nouvelles possibilit\u00e9s de traitement. Cette page vous donne un aper\u00e7u des d\u00e9couvertes r\u00e9centes et des \u00e9tudes en cours.  <\/p>\n\n<h5 class=\"wp-block-heading has--font-size\">Que savons-nous \u00e0 pr\u00e9sent ?<\/h5>\n<style>.wp-block-kadence-advancedheading.kt-adv-heading340_2b75cb-7b_3, .wp-block-kadence-advancedheading.kt-adv-heading340_2b75cb-7b_3[data-kb-block=\"kb-adv-heading340_2b75cb-7b_3\"]{font-style:normal;}.wp-block-kadence-advancedheading.kt-adv-heading340_2b75cb-7b_3 mark.kt-highlight, .wp-block-kadence-advancedheading.kt-adv-heading340_2b75cb-7b_3[data-kb-block=\"kb-adv-heading340_2b75cb-7b_3\"] mark.kt-highlight{font-style:normal;color:#f76a0c;-webkit-box-decoration-break:clone;box-decoration-break:clone;padding-top:0px;padding-right:0px;padding-bottom:0px;padding-left:0px;}.wp-block-kadence-advancedheading.kt-adv-heading340_2b75cb-7b_3 img.kb-inline-image, .wp-block-kadence-advancedheading.kt-adv-heading340_2b75cb-7b_3[data-kb-block=\"kb-adv-heading340_2b75cb-7b_3\"] img.kb-inline-image{width:150px;vertical-align:baseline;}<\/style>\n<p class=\"kt-adv-heading340_2b75cb-7b_3 wp-block-kadence-advancedheading\" data-kb-block=\"kb-adv-heading340_2b75cb-7b_3\">La PTI est une maladie auto-immune dans laquelle les plaquettes (thrombocytes) sont d\u00e9compos\u00e9es plus rapidement et possiblement moins produites.<br\/>Des publications r\u00e9centes indiquent que le PTI ne se limite pas au nombre de plaquettes, mais que la fatigue, les probl\u00e8mes de concentration et la diminution de la qualit\u00e9 de vie jouent \u00e9galement un r\u00f4le important.<br\/>De nouveaux traitements sont en cours de d\u00e9veloppement : outre les th\u00e9rapies classiques (telles que les corticost\u00e9ro\u00efdes, les immunoglobulines intraveineuses et les agonistes des r\u00e9cepteurs de la thrombopo\u00ef\u00e9tine), des agents innovants sont \u00e9galement \u00e9tudi\u00e9s (tels que les inhibiteurs de la voie FcRn, les inhibiteurs de la tyrosine kinase, les th\u00e9rapies ciblant les lymphocytes T).<\/p>\n\n<h5 class=\"wp-block-heading has--font-size\">Y a-t-il des \u00e9tudes en cours ?<\/h5>\n<style>.wp-block-kadence-advancedheading.kt-adv-heading340_2b75cb-7b_7, .wp-block-kadence-advancedheading.kt-adv-heading340_2b75cb-7b_7[data-kb-block=\"kb-adv-heading340_2b75cb-7b_7\"]{font-style:normal;}.wp-block-kadence-advancedheading.kt-adv-heading340_2b75cb-7b_7 mark.kt-highlight, .wp-block-kadence-advancedheading.kt-adv-heading340_2b75cb-7b_7[data-kb-block=\"kb-adv-heading340_2b75cb-7b_7\"] mark.kt-highlight{font-style:normal;color:#f76a0c;-webkit-box-decoration-break:clone;box-decoration-break:clone;padding-top:0px;padding-right:0px;padding-bottom:0px;padding-left:0px;}.wp-block-kadence-advancedheading.kt-adv-heading340_2b75cb-7b_7 img.kb-inline-image, .wp-block-kadence-advancedheading.kt-adv-heading340_2b75cb-7b_7[data-kb-block=\"kb-adv-heading340_2b75cb-7b_7\"] img.kb-inline-image{width:150px;vertical-align:baseline;}<\/style>\n<p class=\"kt-adv-heading340_2b75cb-7b_7 wp-block-kadence-advancedheading\" data-kb-block=\"kb-adv-heading340_2b75cb-7b_7\">Oui, il existe plusieurs \u00e9tudes cliniques en cours sur le PTI, que vous pouvez retrouver dans des registres tels que celui de la <a href=\"https:\/\/www.mayoclinic.org\/\">Mayo Clinic<\/a>.<br\/>Exemples :<br\/>Une \u00e9tude de phase III men\u00e9e aupr\u00e8s de patients adultes atteints de PTI en Chine a examin\u00e9 l&rsquo;efficacit\u00e9 et la s\u00e9curit\u00e9 d&rsquo;un nouveau produit d&rsquo;immunoglobuline intraveineuse \u00e0 10 %.<br\/>Des revues syst\u00e9matiques de la litt\u00e9rature montrent l&rsquo;efficacit\u00e9 et la s\u00e9curit\u00e9 des th\u00e9rapies de deuxi\u00e8me intention dans le PTI.<\/p>\n\n<h5 class=\"wp-block-heading has--font-size\">Pourquoi est-ce pertinent pour vous ?<\/h5>\n<style>.wp-block-kadence-advancedheading.kt-adv-heading340_2b75cb-7b_11, .wp-block-kadence-advancedheading.kt-adv-heading340_2b75cb-7b_11[data-kb-block=\"kb-adv-heading340_2b75cb-7b_11\"]{font-style:normal;}.wp-block-kadence-advancedheading.kt-adv-heading340_2b75cb-7b_11 mark.kt-highlight, .wp-block-kadence-advancedheading.kt-adv-heading340_2b75cb-7b_11[data-kb-block=\"kb-adv-heading340_2b75cb-7b_11\"] mark.kt-highlight{font-style:normal;color:#f76a0c;-webkit-box-decoration-break:clone;box-decoration-break:clone;padding-top:0px;padding-right:0px;padding-bottom:0px;padding-left:0px;}.wp-block-kadence-advancedheading.kt-adv-heading340_2b75cb-7b_11 img.kb-inline-image, .wp-block-kadence-advancedheading.kt-adv-heading340_2b75cb-7b_11[data-kb-block=\"kb-adv-heading340_2b75cb-7b_11\"] img.kb-inline-image{width:150px;vertical-align:baseline;}<\/style>\n<p class=\"kt-adv-heading340_2b75cb-7b_11 wp-block-kadence-advancedheading\" data-kb-block=\"kb-adv-heading340_2b75cb-7b_11\">En tant que patient, ces connaissances scientifiques vous permettent de mieux comprendre votre maladie : quels m\u00e9canismes sont actifs dans l&rsquo;organisme, pourquoi des sympt\u00f4mes tels que la fatigue apparaissent et quelles sont les options futures possibles.<br\/>Pour le m\u00e9decin traitant, cela peut conduire \u00e0 une th\u00e9rapie personnalis\u00e9e : non seulement ax\u00e9e sur l&rsquo;augmentation des plaquettes, mais aussi sur l&rsquo;am\u00e9lioration du fonctionnement quotidien et de la qualit\u00e9 de vie.<br\/>En participant \u00e0 une \u00e9tude, vous pouvez contribuer \u00e0 l&rsquo;accumulation de connaissances et \u00e9ventuellement avoir acc\u00e8s \u00e0 de nouvelles possibilit\u00e9s de traitement.<\/p>\n\n<h5 class=\"wp-block-heading has--font-size\">T\u00e9l\u00e9chargements et liens int\u00e9ressants<\/h5>\n<style>.wp-block-kadence-advancedheading.kt-adv-heading340_2b75cb-7b_15, .wp-block-kadence-advancedheading.kt-adv-heading340_2b75cb-7b_15[data-kb-block=\"kb-adv-heading340_2b75cb-7b_15\"]{font-style:normal;}.wp-block-kadence-advancedheading.kt-adv-heading340_2b75cb-7b_15 mark.kt-highlight, .wp-block-kadence-advancedheading.kt-adv-heading340_2b75cb-7b_15[data-kb-block=\"kb-adv-heading340_2b75cb-7b_15\"] mark.kt-highlight{font-style:normal;color:#f76a0c;-webkit-box-decoration-break:clone;box-decoration-break:clone;padding-top:0px;padding-right:0px;padding-bottom:0px;padding-left:0px;}.wp-block-kadence-advancedheading.kt-adv-heading340_2b75cb-7b_15 img.kb-inline-image, .wp-block-kadence-advancedheading.kt-adv-heading340_2b75cb-7b_15[data-kb-block=\"kb-adv-heading340_2b75cb-7b_15\"] img.kb-inline-image{width:150px;vertical-align:baseline;}<\/style>\n<p class=\"kt-adv-heading340_2b75cb-7b_15 wp-block-kadence-advancedheading\" data-kb-block=\"kb-adv-heading340_2b75cb-7b_15\">Ici, vous pouvez (ou votre association peut) inclure une liste de brochures pertinentes, de r\u00e9sum\u00e9s ou de liens vers des synth\u00e8ses de recherche fiables que les patients peuvent t\u00e9l\u00e9charger.<br\/>Exemple : <a href=\"https:\/\/link.springer.com\/article\/10.1007\/s44337-024-00040-8\" data-type=\"link\" data-id=\"https:\/\/link.springer.com\/article\/10.1007\/s44337-024-00040-8\">Immune thrombocytopenia: a review of pathogenesis and current treatment<\/a> (2024).<br\/>Lignes directrices pour le d\u00e9veloppement clinique de produits dans le cadre du PTI chronique (Agence europ\u00e9enne des m\u00e9dicaments).<\/p>\n\n<h5 class=\"wp-block-heading has--font-size\">\u00c9tudes cliniques actuelles<\/h5>\n<style>.wp-block-kadence-advancedheading.kt-adv-heading340_2ff458-e8_0, .wp-block-kadence-advancedheading.kt-adv-heading340_2ff458-e8_0[data-kb-block=\"kb-adv-heading340_2ff458-e8_0\"]{font-style:normal;}.wp-block-kadence-advancedheading.kt-adv-heading340_2ff458-e8_0 mark.kt-highlight, .wp-block-kadence-advancedheading.kt-adv-heading340_2ff458-e8_0[data-kb-block=\"kb-adv-heading340_2ff458-e8_0\"] mark.kt-highlight{font-style:normal;color:#f76a0c;-webkit-box-decoration-break:clone;box-decoration-break:clone;padding-top:0px;padding-right:0px;padding-bottom:0px;padding-left:0px;}.wp-block-kadence-advancedheading.kt-adv-heading340_2ff458-e8_0 img.kb-inline-image, .wp-block-kadence-advancedheading.kt-adv-heading340_2ff458-e8_0[data-kb-block=\"kb-adv-heading340_2ff458-e8_0\"] img.kb-inline-image{width:150px;vertical-align:baseline;}<\/style>\n<p class=\"kt-adv-heading340_2ff458-e8_0 wp-block-kadence-advancedheading\" data-kb-block=\"kb-adv-heading340_2ff458-e8_0\">Vous trouverez ci-dessous une liste abr\u00e9g\u00e9e des \u00e9tudes cliniques actuelles sur la thrombocytop\u00e9nie immune (PTI) en Belgique et\/ou en Europe qui sont actuellement actives ou en cours de recrutement. Cette liste n&rsquo;est pas exhaustive, mais donne un bon aper\u00e7u des recherches en cours auxquelles les patients peuvent \u00e9ventuellement participer ou sur lesquelles vous pouvez vous renseigner. <\/p>\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-8f761849 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:100%\">\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-8f761849 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<p class=\"wp-block-paragraph\"><strong>\u00c9tude<\/strong><\/p>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<p class=\"wp-block-paragraph\"><strong>Phase et objectif<\/strong><\/p>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<p class=\"wp-block-paragraph\"><strong>Lieu \/ remarques<\/strong><\/p>\n<\/div>\n<\/div>\n\n\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-8f761849 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<p class=\"wp-block-paragraph\">VAYHIT2 (avec Ianalumab + Eltrombopag)<\/p>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<p class=\"wp-block-paragraph\">Phase III : efficacit\u00e9 et s\u00e9curit\u00e9 de l&rsquo;ianalumab + eltrombopag chez les adultes atteints de PTI primaire qui n&rsquo;ont pas suffisamment r\u00e9pondu aux corticost\u00e9ro\u00efdes. <a href=\"https:\/\/globalitp.org\/index.php\/global-studies\/clinical-trials?utm_source=chatgpt.com\" target=\"_blank\" rel=\"noreferrer noopener\">globalitp.org<\/a><\/p>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td>\u00c9tude multinationale europ\u00e9enne, Belgique incluse.<\/td><\/tr><\/tbody><\/table><\/figure>\n<\/div>\n<\/div>\n\n\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-8f761849 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<p class=\"wp-block-paragraph\">VAYHIT1 (avec ianalumab vs placebo dans la PTI de premi\u00e8re ligne)<\/p>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<p class=\"wp-block-paragraph\">Phase III : comparer l&rsquo;ianalumab vs le placebo en association avec le traitement standard chez les adultes atteints de PTI primaire. <a href=\"https:\/\/globalitp.org\/index.php\/global-studies\/clinical-trials?utm_source=chatgpt.com\" target=\"_blank\" rel=\"noreferrer noopener\">globalitp.org<\/a><\/p>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<p class=\"wp-block-paragraph\">Participation europ\u00e9enne, Belgique \u00e9galement possible.<\/p>\n<\/div>\n<\/div>\n\n\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-8f761849 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td>ARGX\u2011113\u20111603 dans la PTI<\/td><\/tr><\/tbody><\/table><\/figure>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<p class=\"wp-block-paragraph\">Phase II : \u00e9valuation de la s\u00e9curit\u00e9, de l&rsquo;efficacit\u00e9 et de la pharmacocin\u00e9tique de l&rsquo;ARGX-113 chez les patients atteints de PTI primaire. <a href=\"https:\/\/www.uzleuven.be\/nl\/hematologie\/klinische-studies\/immuun-trombocytopenische-purpura-itp?utm_source=chatgpt.com\" target=\"_blank\" rel=\"noreferrer noopener\">UZ Leuven<\/a><\/p>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<p class=\"wp-block-paragraph\">\u00c9tude mentionn\u00e9e par l&rsquo;UZ Leuven (Belgique) comme possibilit\u00e9 de site.<\/p>\n<\/div>\n<\/div>\n\n\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-8f761849 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<p class=\"wp-block-paragraph\">RAINBOW Trial (avec RAY121)<\/p>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<p class=\"wp-block-paragraph\">Phase 1b \u00ab basket-trial \u00bb : s\u00e9curit\u00e9\/tol\u00e9rabilit\u00e9 d&rsquo;un inhibiteur du compl\u00e9ment dans les maladies auto-immunes, dont la PTI. <a href=\"https:\/\/globalitp.org\/index.php\/global-studies\/clinical-trials?utm_source=chatgpt.com\" target=\"_blank\" rel=\"noreferrer noopener\">globalitp.org<\/a><\/p>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td>Pays europ\u00e9ens impliqu\u00e9s, dont la Belgique.<\/td><\/tr><\/tbody><\/table><\/figure>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n\n<h4 class=\"wp-block-heading has--font-size\">Qu&rsquo;est-ce que cela signifie pour vous ?<\/h4>\n<style>.wp-block-kadence-advancedheading.kt-adv-heading340_331308-6a_1, .wp-block-kadence-advancedheading.kt-adv-heading340_331308-6a_1[data-kb-block=\"kb-adv-heading340_331308-6a_1\"]{font-style:normal;}.wp-block-kadence-advancedheading.kt-adv-heading340_331308-6a_1 mark.kt-highlight, .wp-block-kadence-advancedheading.kt-adv-heading340_331308-6a_1[data-kb-block=\"kb-adv-heading340_331308-6a_1\"] mark.kt-highlight{font-style:normal;color:#f76a0c;-webkit-box-decoration-break:clone;box-decoration-break:clone;padding-top:0px;padding-right:0px;padding-bottom:0px;padding-left:0px;}.wp-block-kadence-advancedheading.kt-adv-heading340_331308-6a_1 img.kb-inline-image, .wp-block-kadence-advancedheading.kt-adv-heading340_331308-6a_1[data-kb-block=\"kb-adv-heading340_331308-6a_1\"] img.kb-inline-image{width:150px;vertical-align:baseline;}<\/style>\n<p class=\"kt-adv-heading340_331308-6a_1 wp-block-kadence-advancedheading\" data-kb-block=\"kb-adv-heading340_331308-6a_1\">Ces \u00e9tudes montrent qu&rsquo;il existe une recherche active pour d\u00e9velopper de nouveaux traitements pour la PTI ou pour am\u00e9liorer les traitements existants.<br\/>Les patients en Belgique peuvent \u00e9ventuellement participer ou \u00eatre pris en consid\u00e9ration pour une demande de participation, cela d\u00e9pend des crit\u00e8res d&rsquo;inclusion sp\u00e9cifiques (\u00e2ge, stade de la maladie, traitements ant\u00e9rieurs).<br\/>La participation \u00e0 une \u00e9tude clinique implique \u00e0 la fois une opportunit\u00e9 et une responsabilit\u00e9 : une nouvelle th\u00e9rapie ou combinaison est \u00e9valu\u00e9e, mais elle implique \u00e9galement des examens, des visites ou des contr\u00f4les suppl\u00e9mentaires. Il est important d&rsquo;\u00eatre bien inform\u00e9 \u00e0 ce sujet par le m\u00e9decin traitant. <\/p>\n\n<h4 class=\"wp-block-heading has--font-size\">Et apr\u00e8s ?<\/h4>\n<style>.wp-block-kadence-advancedheading.kt-adv-heading340_331308-6a_5, .wp-block-kadence-advancedheading.kt-adv-heading340_331308-6a_5[data-kb-block=\"kb-adv-heading340_331308-6a_5\"]{font-style:normal;}.wp-block-kadence-advancedheading.kt-adv-heading340_331308-6a_5 mark.kt-highlight, .wp-block-kadence-advancedheading.kt-adv-heading340_331308-6a_5[data-kb-block=\"kb-adv-heading340_331308-6a_5\"] mark.kt-highlight{font-style:normal;color:#f76a0c;-webkit-box-decoration-break:clone;box-decoration-break:clone;padding-top:0px;padding-right:0px;padding-bottom:0px;padding-left:0px;}.wp-block-kadence-advancedheading.kt-adv-heading340_331308-6a_5 img.kb-inline-image, .wp-block-kadence-advancedheading.kt-adv-heading340_331308-6a_5[data-kb-block=\"kb-adv-heading340_331308-6a_5\"] img.kb-inline-image{width:150px;vertical-align:baseline;}<\/style>\n<p class=\"kt-adv-heading340_331308-6a_5 wp-block-kadence-advancedheading\" data-kb-block=\"kb-adv-heading340_331308-6a_5\">Demandez \u00e0 votre h\u00e9matologue ou \u00e0 votre m\u00e9decin traitant s&rsquo;il est au courant des \u00e9tudes en cours sur le PTI et si vous pourriez \u00eatre \u00e9ligible.<br\/>Consultez les bases de donn\u00e9es d&rsquo;essais cliniques telles que ClinicalTrials.gov ou les \u00e9quivalents europ\u00e9ens pour consulter les d\u00e9tails actuels (phase, lieux, crit\u00e8res d&rsquo;inclusion).<br\/>Renseignez-vous sur les r\u00e9sultats des \u00e9tudes pr\u00e9c\u00e9dentes et sur ce que cela signifie pour votre traitement ou votre choix de th\u00e9rapie. Parfois, cela signifie une politique d&rsquo;attente et de surveillance, parfois, la participation peut \u00eatre utile.<\/p>\n\n<h4 class=\"wp-block-heading has--font-size\">Articles scientifiques et directives t\u00e9l\u00e9chargeables gratuitement<\/h4>\n\n<p class=\"has--font-size wp-block-paragraph\">American Society of Hematology (ASH) 2019 \u00ab Clinical Practice Guidelines for Immune Thrombocytopenia (PTI) \u00bb. Cette directive est compl\u00e8te et actualis\u00e9e, et disponible gratuitement au format PDF.  <a href=\"https:\/\/docslib.org\/doc\/9292531\/american-society-of-hematology-2019-guidelines-for-immune-thrombocytopenia?utm_source=chatgpt.com\" target=\"_blank\" rel=\"noreferrer noopener\">docslib.org+2hematology.org+2<\/a><br\/><br\/>ASH 2019 \u00ab Pocket Guide : Management of Immune Thrombocytopenia (PTI) \u2013 A Pocket Guide for the Clinician \u00bb. Version pratique plus courte, \u00e9galement t\u00e9l\u00e9chargeable gratuitement.  <a href=\"https:\/\/www.hematology.org\/-\/media\/hematology\/files\/education\/clinicians\/guidelines-quality\/documents\/ash-itp-pocket-guide-for-web-1204.pdf?utm_source=chatgpt.com\" target=\"_blank\" rel=\"noreferrer noopener\">hematology.org+1<\/a><br\/><br\/>European Society for Blood and Marrow Transplantation (EBMT) \u2013 \u00ab Practical Guides for Immune Thrombocytopenia \u00bb (diff\u00e9rentes langues). Guides PDF gratuits pour les professionnels et \u00e9ventuellement les patients.  <a href=\"https:\/\/www.ebmt.org\/practical-guides-immune-thrombocytopenia?utm_source=chatgpt.com\" target=\"_blank\" rel=\"noreferrer noopener\">ebmt.org+1<\/a><br\/><br\/>\u00ab Burden of immune thrombocytopenia (PTI) : Special considerations for refractory ITP \u00bb, publi\u00e9 dans le <em>British Journal of Haematology<\/em> (2023) \u2014 disponible gratuitement sous forme de PDF\/\u00e9tude de fond. <a href=\"https:\/\/www.ovid.com\/journals\/bjha\/pdf\/10.1111\/bjh.19068~burden-of-immune-thrombocytopenia-itp-special-considerations?utm_source=chatgpt.com\" target=\"_blank\" rel=\"noreferrer noopener\">ovid.com<\/a><br\/><br\/>\u00ab Protocol for the study and treatment of primary immune thrombocytopenia: ITP-2018 \u00bb (Espagne) \u2014 article en libre acc\u00e8s avec un bon aper\u00e7u de l&rsquo;\u00e9tude et du traitement du PTI primaire. <a href=\"https:\/\/www.analesdepediatria.org\/en-protocol-for-study-treatment-primary-articulo-S2341287919301152?utm_source=chatgpt.com\" target=\"_blank\" rel=\"noreferrer noopener\">analesdepediatria.org<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Les connaissances m\u00e9dicales sur la PTI ne cessent d&rsquo;\u00e9voluer, ce qui est une bonne nouvelle pour les patients et les prestataires de soins. Des chercheurs du monde entier se penchent&#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":1089,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_EventAllDay":false,"_EventTimezone":"","_EventStartDate":"","_EventEndDate":"","_EventStartDateUTC":"","_EventEndDateUTC":"","_EventShowMap":false,"_EventShowMapLink":false,"_EventURL":"","_EventCost":"","_EventCostDescription":"","_EventCurrencySymbol":"","_EventCurrencyCode":"","_EventCurrencyPosition":"","_EventDateTimeSeparator":"","_EventTimeRangeSeparator":"","_EventOrganizerID":[],"_EventVenueID":[],"_OrganizerEmail":"","_OrganizerPhone":"","_OrganizerWebsite":"","_VenueAddress":"","_VenueCity":"","_VenueCountry":"","_VenueProvince":"","_VenueState":"","_VenueZip":"","_VenuePhone":"","_VenueURL":"","_VenueStateProvince":"","_VenueLat":"","_VenueLng":"","_VenueShowMap":false,"_VenueShowMapLink":false,"_kadence_starter_templates_imported_post":false,"_kad_post_transparent":"","_kad_post_title":"","_kad_post_layout":"","_kad_post_sidebar_id":"","_kad_post_content_style":"","_kad_post_vertical_padding":"","_kad_post_feature":"","_kad_post_feature_position":"","_kad_post_header":false,"_kad_post_footer":false,"_kad_post_classname":"","footnotes":""},"class_list":["post-1007","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/www.itpptibelgium.be\/fr\/wp-json\/wp\/v2\/pages\/1007","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.itpptibelgium.be\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.itpptibelgium.be\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.itpptibelgium.be\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.itpptibelgium.be\/fr\/wp-json\/wp\/v2\/comments?post=1007"}],"version-history":[{"count":6,"href":"https:\/\/www.itpptibelgium.be\/fr\/wp-json\/wp\/v2\/pages\/1007\/revisions"}],"predecessor-version":[{"id":2757,"href":"https:\/\/www.itpptibelgium.be\/fr\/wp-json\/wp\/v2\/pages\/1007\/revisions\/2757"}],"up":[{"embeddable":true,"href":"https:\/\/www.itpptibelgium.be\/fr\/wp-json\/wp\/v2\/pages\/1089"}],"wp:attachment":[{"href":"https:\/\/www.itpptibelgium.be\/fr\/wp-json\/wp\/v2\/media?parent=1007"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}